Basal and IL-1β enhanced chondrocyte chemotactic activity on monocytes are co-dependent on both IKKα and IKKβ NF-κB activating kinases.
Cells, Cultured
Chemokine CCL2
/ metabolism
Chemokines
/ immunology
Chemotaxis
/ physiology
Chondrocytes
/ metabolism
Female
Humans
I-kappa B Kinase
/ metabolism
Inflammation
Interleukin-1beta
/ metabolism
Male
Middle Aged
Monocytes
/ metabolism
NF-kappa B
/ metabolism
Osteoarthritis
/ metabolism
Phosphorylation
Protein Serine-Threonine Kinases
Signal Transduction
/ physiology
Transcription Factor RelA
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 11 2021
04 11 2021
Historique:
received:
14
05
2021
accepted:
18
10
2021
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
27
1
2022
Statut:
epublish
Résumé
IKKα and IKKβ are essential kinases for activating NF-κB transcription factors that regulate cellular differentiation and inflammation. By virtue of their small size, chemokines support the crosstalk between cartilage and other joint compartments and contribute to immune cell chemotaxis in osteoarthritis (OA). Here we employed shRNA retroviruses to stably and efficiently ablate the expression of each IKK in primary OA chondrocytes to determine their individual contributions for monocyte chemotaxis in response to chondrocyte conditioned media. Both IKKα and IKKβ KDs blunted both the monocyte chemotactic potential and the protein levels of CCL2/MCP-1, the chemokine with the highest concentration and the strongest association with monocyte chemotaxis. These findings were mirrored by gene expression analysis indicating that the lowest levels of CCL2/MCP-1 and other monocyte-active chemokines were in IKKαKD cells under both basal and IL-1β stimulated conditions. We find that in their response to IL-1β stimulation IKKαKD primary OA chondrocytes have reduced levels of phosphorylated NFkappaB p65pSer536 and H3pSer10. Confocal microscopy analysis revealed co-localized p65 and H3pSer10 nuclear signals in agreement with our findings that IKKαKD effectively blunts their basal level and IL-1β dependent increases. Our results suggest that IKKα could be a novel OA disease target.
Identifiants
pubmed: 34737366
doi: 10.1038/s41598-021-01063-2
pii: 10.1038/s41598-021-01063-2
pmc: PMC8568921
doi:
Substances chimiques
CCL2 protein, human
0
Chemokine CCL2
0
Chemokines
0
IL1B protein, human
0
Interleukin-1beta
0
NF-kappa B
0
RELA protein, human
0
Transcription Factor RelA
0
Protein Serine-Threonine Kinases
EC 2.7.11.1
TBK1 protein, human
EC 2.7.11.1
I-kappa B Kinase
EC 2.7.11.10
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21697Subventions
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca, Italy
ID : FIRB Grant: RBAP10KCNS
Organisme : Ministero della Salute, Italy
ID : Fondi Cinque per Mille to the IRCCS Istituto Ortopedico Rizzoli
Informations de copyright
© 2021. The Author(s).
Références
Sci Rep. 2021 Jan 13;11(1):1053
pubmed: 33441764
Arthritis Res Ther. 2010;12(1):R18
pubmed: 20113495
Osteoarthritis Cartilage. 2017 Mar;25(3):406-412
pubmed: 27746376
Nat Immunol. 2002 Jan;3(1):69-75
pubmed: 11743587
J Cell Biochem. 2008 Jul 1;104(4):1393-406
pubmed: 18286508
Eur Cell Mater. 2011 Feb 24;21:202-20
pubmed: 21351054
Cell Signal. 2019 Jan;53:212-223
pubmed: 30312659
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000067
pubmed: 20066093
J Biol Chem. 2006 Jul 7;281(27):18684-90
pubmed: 16675465
Nature. 2001 Apr 5;410(6829):710-4
pubmed: 11287960
J Cell Sci. 1988 Mar;89 ( Pt 3):373-8
pubmed: 3058725
J Neuroinflammation. 2021 Mar 23;18(1):79
pubmed: 33757529
Curr Drug Targets. 2007 Feb;8(2):367-76
pubmed: 17305514
J Orthop Surg Res. 2020 Nov 10;15(1):516
pubmed: 33168099
J Biol Chem. 2007 Jul 20;282(29):21308-18
pubmed: 17537731
J Cell Physiol. 2007 Feb;210(2):417-27
pubmed: 17096385
Osteoarthritis Cartilage. 2018 Sep;26(9):1257-1261
pubmed: 29723633
Curr Drug Targets. 2007 Feb;8(2):377-85
pubmed: 17305515
Oncogene. 2008 Oct 2;27(44):5833-44
pubmed: 18560356
Genes Dis. 2015 Dec;2(4):307-327
pubmed: 26835506
Arthritis Rheum. 2008 Jan;58(1):227-39
pubmed: 18163512
Cell Rep. 2012 Oct 25;2(4):824-39
pubmed: 23063365
Curr Opin Rheumatol. 2011 Sep;23(5):471-8
pubmed: 21788902
J Cell Biochem. 2006 Jan 1;97(1):33-44
pubmed: 16215986
Ann Rheum Dis. 2017 May;76(5):914-922
pubmed: 27965260
Sci Rep. 2019 Jun 20;9(1):8905
pubmed: 31222033
PLoS One. 2010 Feb 25;5(2):e9428
pubmed: 20195534
J Orthop Res. 2017 Apr;35(4):735-739
pubmed: 27808445
Nature. 2004 Apr 8;428(6983):660-4
pubmed: 15071597
Arthritis Rheum. 2010 Aug;62(8):2370-81
pubmed: 20506238
Ageing Res Rev. 2008 Apr;7(2):106-13
pubmed: 18054526
Methods Mol Biol. 2012;806:301-36
pubmed: 22057461
Ageing Res Rev. 2016 Aug;29:50-65
pubmed: 27328278
Immunol Rev. 2012 Mar;246(1):239-53
pubmed: 22435559
Osteoarthritis Cartilage. 2017 Apr;25(4):589-599
pubmed: 27836674
Arthritis Res Ther. 2019 Jun 13;21(1):146
pubmed: 31196179
Mol Cell. 2004 Oct 22;16(2):245-55
pubmed: 15494311
Nat Rev Rheumatol. 2012 Sep;8(9):543-52
pubmed: 22890245
PLoS One. 2013 Sep 02;8(9):e73024
pubmed: 24023802
Methods Mol Biol. 2004;285:171-7
pubmed: 15269412
Oxid Med Cell Longev. 2018 Feb 11;2018:3075293
pubmed: 29599894
Ther Adv Musculoskelet Dis. 2013 Apr;5(2):77-94
pubmed: 23641259
J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1209-17
pubmed: 23689830
Arthritis Rheum. 2008 Jul;58(7):2075-87
pubmed: 18576389
Biosci Rep. 2016 May 06;36(3):
pubmed: 27129293
Free Radic Biol Med. 2021 Apr;166:212-225
pubmed: 33636333
Science. 1999 Apr 9;284(5412):316-20
pubmed: 10195896
J Immunol. 2018 Oct 1;201(7):1918-1927
pubmed: 30135182
Trends Cell Biol. 2021 Mar;31(3):166-178
pubmed: 33422358
Nature. 2003 Jun 5;423(6940):655-9
pubmed: 12789342
EMBO Rep. 2014 Jan;15(1):46-61
pubmed: 24375677
Nat Rev Rheumatol. 2016 Nov;12(11):669-683
pubmed: 27733758
Nature. 2003 Jun 5;423(6940):659-63
pubmed: 12789343
Clin Rheumatol. 2008 Sep;27(9):1127-34
pubmed: 18414968
Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):57-63
pubmed: 31621560
J Cell Sci. 2003 Sep 15;116(Pt 18):3677-85
pubmed: 12917355
Ann Rheum Dis. 2005 Sep;64(9):1263-7
pubmed: 15731292
J Biol Chem. 2002 Nov 22;277(47):45129-40
pubmed: 12221085
Osteoarthritis Cartilage. 2007 Sep;15(9):1061-9
pubmed: 17470400
Cell. 1997 Oct 17;91(2):243-52
pubmed: 9346241
Curr Rheumatol Rep. 2017 Mar;19(3):11
pubmed: 28265846
J Clin Invest. 2001 Jan;107(2):135-42
pubmed: 11160126
Curr Drug Targets. 2010 May;11(5):599-613
pubmed: 20199390
Cell. 2007 Sep 7;130(5):918-31
pubmed: 17803913
Arthritis Rheumatol. 2018 Feb;70(2):185-192
pubmed: 29178176
Sci Rep. 2019 Sep 19;9(1):13603
pubmed: 31537813
Pharm Res. 2018 Apr 20;35(6):123
pubmed: 29679159
Osteoarthritis Cartilage. 2020 May;28(5):613-625
pubmed: 32006659
Nat Rev Rheumatol. 2010 Nov;6(11):625-35
pubmed: 20924410
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20798-803
pubmed: 19104039
Sci Rep. 2019 Oct 3;9(1):14269
pubmed: 31582764